ADDUCI, CARMEN
 Distribuzione geografica
Continente #
NA - Nord America 2.002
AS - Asia 1.604
EU - Europa 836
SA - Sud America 191
AF - Africa 61
Totale 4.694
Nazione #
US - Stati Uniti d'America 1.964
SG - Singapore 580
DE - Germania 268
HK - Hong Kong 268
CN - Cina 247
VN - Vietnam 195
IT - Italia 194
BR - Brasile 143
IN - India 143
FI - Finlandia 47
FR - Francia 46
RU - Federazione Russa 46
IE - Irlanda 40
AT - Austria 35
GB - Regno Unito 33
SE - Svezia 33
BG - Bulgaria 27
JP - Giappone 25
BD - Bangladesh 23
AR - Argentina 20
TR - Turchia 20
TG - Togo 18
ID - Indonesia 17
NL - Olanda 17
CA - Canada 16
MX - Messico 16
ZA - Sudafrica 14
RO - Romania 13
IQ - Iraq 12
MY - Malesia 9
UA - Ucraina 9
EC - Ecuador 8
KR - Corea 8
PK - Pakistan 7
PL - Polonia 7
MA - Marocco 6
PH - Filippine 6
DZ - Algeria 5
UY - Uruguay 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
JO - Giordania 4
KZ - Kazakistan 4
RS - Serbia 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CL - Cile 3
ES - Italia 3
IL - Israele 3
KE - Kenya 3
OM - Oman 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CO - Colombia 2
GN - Guinea 2
HN - Honduras 2
JM - Giamaica 2
LV - Lettonia 2
NG - Nigeria 2
NP - Nepal 2
SY - Repubblica araba siriana 2
BE - Belgio 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GY - Guiana 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
SN - Senegal 1
TW - Taiwan 1
YT - Mayotte 1
ZW - Zimbabwe 1
Totale 4.694
Città #
Singapore 326
Hong Kong 253
Fairfield 201
Ashburn 182
San Jose 172
Woodbridge 105
Seattle 96
Cambridge 84
Chandler 79
Santa Clara 75
Houston 74
Wilmington 73
Rome 65
Los Angeles 63
Ho Chi Minh City 59
Hanoi 52
Hefei 48
Beijing 47
Princeton 38
Buffalo 35
Dallas 34
New York 34
Ann Arbor 27
Lauterbourg 27
Sofia 27
Dublin 26
San Paolo di Civitate 26
Lawrence 25
Plano 25
Vienna 25
Cosenza 23
Frankfurt am Main 23
Dearborn 21
Faridabad 21
The Dalles 21
Council Bluffs 20
Tokyo 20
Lomé 18
San Diego 18
Helsinki 15
Millbury 15
Munich 15
Noida 15
Redondo Beach 15
Boston 14
Turku 14
São Paulo 13
Chicago 12
Johannesburg 12
Milan 12
Andover 10
Nuremberg 10
Amsterdam 9
Jakarta 9
London 9
Hillsboro 8
Baghdad 7
Bengaluru 7
Haiphong 7
Istanbul 7
Moscow 7
Columbus 6
Orem 6
Pune 6
Warsaw 6
Atlanta 5
Biên Hòa 5
Da Nang 5
Fremont 5
Lahore 5
Montevideo 5
Norwalk 5
Toronto 5
Ankara 4
Boardman 4
Can Tho 4
Casablanca 4
Denver 4
Falkenstein 4
Guangzhou 4
Hải Dương 4
Kuala Lumpur 4
Lappeenranta 4
Paris 4
Phoenix 4
Riyadh 4
Zhengzhou 4
Ấp Tháp Mười 4
Astana 3
Buenos Aires 3
Chennai 3
City of London 3
Des Moines 3
Elk Grove Village 3
Marano di Napoli 3
Menlo Park 3
Montreal 3
Nairobi 3
Ottawa 3
Oxford 3
Totale 2.990
Nome #
Eligibility for the subcutaneous implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy 176
Pulmonary hypertension and clinical correlates in hypertrophic cardiomyopathy 164
Prognostic implications of defibrillation threshold testing in patients with hypertrophic cardiomyopathy 158
RyR2 common gene variant G1886S and the risk of ventricular arrhythmias in ICD patients with heart failure. 157
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 153
Atrial natriuretic peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation 146
Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome 146
Angiotensin receptor antagonists to prevent sudden death in heart failure: does the dose matter? 145
Clinical Impact of Nonsustained Ventricular Tachycardia Recorded by the Implantable Cardioverter-Defibrillator in Patients with Hypertrophic Cardiomyopathy. 138
Home delivery of the communicator for remote monitoring of cardiac implantable devices: a multicenter experience during the covid-19 lockdown 133
P-Wave Duration in Lead aVR and the Risk of Atrial Fibrillation in Hypertension. 131
Osteopontin and Galectin-3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators. 131
Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator 127
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool 126
Safety and efficacy of anti-tachycardia pacing in patients with hypertrophic cardiomyopathy implanted with an ICD 125
An unusual pattern of Para-Hisian pacing. The role of infra-Hisian conduction delay 122
Autonomic cardiovascular control and cardiac arrhythmia in two pregnant women with hypertrophic cardiomyopathy: Insights from ICD monitoring 120
Supraventricular arrhythmia with discordant electrocardiographic features. What is the arrhythmia mechanism? 118
Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator 114
Premature ventricular extrastimulus without His or ventricular capture. An unexpected response during AV nodal reentrant tachycardia 114
The subcutaneous implantable cardioverter-defibrillator. Current trends in clinical practice between guidelines and technology progress 112
Acute shock efficacy of the subcutaneous implantable cardioverter-defibrillator according to the implantation technique 111
A mobile app for improving the compliance with remote management of patients with cardiac implantable devices. a multicenter evaluation in clinical practice 110
Common genetic variants in selected Ca2+ signaling genes and the risk of appropriate ICD interventions in patients with heart failure 108
Gene variants of calcium handling proteins as a determinant of ventricular arrhythmias in ICD recipients with heart failure 106
Prevention of sudden cardiac death: focus on the subcutaneous implantable cardioverter-defibrillator 106
Calcium Handling Proteins Common Gene Variants And Risk Of Ventricular Arrhythmias In ICD Recipients With Heart Failure. 100
Multi-modality imaging approach in a challenging case of surgically corrected partial anomalous pulmonary venous return and atrial tachycardia treated with radiofrequency ablation 100
Calcium handling proteins gene variants and the risk of ventricular arrhythmias in ICD recipients with heart failure: focus on extremely opposing phenotypes 99
Assessing Atrial Fibrillation Substrates by P Wave Analysis. A Comprehensive Review 94
Genetic deletion of the p66Shc adaptor protein protects against age-related cardiac arrhythmias. 93
Substrates of scar-related ventricular arrhythmia in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study 92
null 91
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy 90
New oral anticoagulants in non-valvular atrial fibrillation. 87
Implantation technique and optimal subcutaneous defibrillator chest position: a PRAETORIAN score-based study 86
Left ventricular remodeling in hypertrophic cardiomyopathy: an overview of current knowledge 84
Prognostic implications of non-sustained VT morphology in high-risk patients with HCM 84
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 83
Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or a subcutaneous defibrillator 77
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathy 75
Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy 64
Subcutaneous implantable defibrillators in young patients: arrhythmias, complications, and physical activity 58
Totale 4.854
Categoria #
all - tutte 14.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.231


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 20 12
2021/2022377 7 16 33 33 54 11 7 32 30 26 70 58
2022/2023370 61 82 14 16 42 34 9 26 46 4 19 17
2023/2024215 14 28 7 21 15 60 3 8 2 22 21 14
2024/2025915 5 84 42 18 82 36 50 29 158 77 70 264
2025/20261.900 161 68 162 143 295 86 328 119 199 239 100 0
Totale 4.854